Sponsor

Cephalon

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Cephalon appears in 29 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials29
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

29 shown
Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung CancerNCT01563601 · lead sponsor · 2012-08-01
WITHDRAWN
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01305408 · lead sponsor · 2011-03-01
COMPLETED
Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01121536 · lead sponsor · 2010-04-30
TERMINATED
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01072630 · lead sponsor · 2010-03-01
COMPLETED
A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01072929 · lead sponsor · 2010-01-01
COMPLETED
Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With SchizophreniaNCT00772005 · lead sponsor · 2008-09-01
COMPLETED
Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and DepressionNCT00518986 · lead sponsor · 2007-10-01
COMPLETED
Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive DeficitsNCT00487942 · lead sponsor · 2007-07-01
COMPLETED
Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT00481195 · lead sponsor · 2007-06-01
COMPLETED
Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough PainNCT00228605 · lead sponsor · 2005-03-01
COMPLETED
Study of CEP-701 in Treatment of Prostate CancerNCT00081601 · lead sponsor · 2004-03-01
COMPLETED
Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's DiseaseNCT00040404 · lead sponsor · 2002-03-01
TERMINATED
Study of Arsenic Trioxide in Small Cell Lung CancerNCT01470248 · collaborator · 2011-08-01
COMPLETED
A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast CancerNCT01367028 · collaborator · 2011-06-01
COMPLETED
Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy BodiesNCT01256905 · collaborator · 2011-01-01
WITHDRAWN
Armodafinil in Binge Eating Disorder (BED)NCT01010789 · collaborator · 2009-11-01
COMPLETED
A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)NCT00682981 · collaborator · 2008-05-01
COMPLETED
Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled AsthmaNCT00587288 · collaborator · 2008-04-01
COMPLETED
A Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler ImagingNCT00531973 · collaborator · 2007-01-01
UNKNOWN
Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast CancerNCT00377780 · collaborator · 2006-08-01
TERMINATED
Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective DisorderNCT00373672 · collaborator · 2006-08-01
COMPLETED
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)NCT00453804 · collaborator · 2006-07-01
COMPLETED
Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast CancerNCT00377559 · collaborator · 2006-05-01
COMPLETED
Treatment of Apathy in Alzheimer's Disease With ModafinilNCT01172145 · collaborator · 2005-07-01
COMPLETED
Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer PatientsNCT00129896 · collaborator · 2004-01-01
COMPLETED
A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With SchizophreniaNCT00573417 · collaborator · 2003-09-01
COMPLETED
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep ApneaNCT00089752 · collaborator · 2003-09-01
COMPLETED
Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.NCT00208715 · collaborator · 2003-02-01
COMPLETED
Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With SchizophreniaNCT00546403 · collaborator · 2003-02-01
COMPLETED

Drugs studied in this sponsor's trials

8 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Cephalon as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo11
armodafinil10
modafinil3
arsenic trioxide1
docetaxel1
epirubicin1
Herceptin1
Provigil1
placebo RxCUI 8375 · Lead sponsor in 7 linked trial(s) · 0 currently recruiting 11 trials armodafinil RxCUI 641465 · Lead sponsor in 8 linked trial(s) · 0 currently recruiting 10 trials modafinil RxCUI 30125 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 3 trials arsenic trioxide RxCUI 18330 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial docetaxel RxCUI 72962 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial epirubicin RxCUI 3995 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial Herceptin RxCUI 101306 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial Provigil RxCUI 219484 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator17
lead sponsor12
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.